Quality of care includes proper treatment, including lifestyle changes and appropriate medication use. This section presents current albuminuria testing rates among Veterans, medication use for indicated drugs (angiotensin-converting enzyme inhibitors [ACEi], angiotensin receptor blockers [ARBs], and sodium-glucose cotransporter-2 [SGLT2] inhibitors [among kidney patients with diabetes]), and the avoidance of medications that are toxic to kidneys, including nonsteroidal anti-inflammatory drugs (NSAIDS). These metrics were examined among patients from the Veteran’s Health Administration, study participants (weighting to the US population) from the National Health and Nutrition Examination Survey (NHANES), and insured individuals from the Optum® Clinformatics® database. Additional quality of care measures will be included in subsequent Kidney Disease Surveillance System updates.

---